baltimore conference logo
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Transarterial Yttrium-90 Radioembolization with Chemotherapy for the Treatment of Colorectal Liver Metastasis: The EPOCH Study

Mary F. Mulcahy, MD, breaks down the phase III EPOCH study and explains how it has affected the treatment of colorectal cancer with liver metastasis.

EP. 1: Treatment Options for Colorectal Cancer with Liver Metastasis

November 1st 2021

Mary F. Mulcahy, MD, describes the treatment options available for colorectal cancer with liver metastasis in the first and second line.

EP. 2: Radioembolization in Colorectal Cancer with Liver Metastasis

November 5th 2021

Dr Mary Mulcahy, an expert oncologist, details how radioembolization is involved in the treatment of colorectal cancer with liver metastasis.

EP. 3: The EPOCH Trial: Rationale and Design

November 5th 2021

Dr Mary Mulcahy explains the rationale and study design of the phase III EPOCH clinical trial.

EP. 4: The EPOCH Trial: Efficacy and Safety

November 5th 2021

Dr Mary Mulcahy, a key opinion leader, describes the efficacy and safety outcomes of the EPOCH clinical trial.

EP. 5: Implications of the EPOCH Trial in Clinical Practice

November 5th 2021

Mary F. Mulcahy discusses the potential implications of the EPOCH trial in clinical practice.